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ABSTRACT 
The skyrocketing costs of prescription medicine in developed countries and their 
lack of availability in developing countries are the most challenging problems of human 
health.  Primary reasons for such high cost are fermentation-based production, expensive 
purification methods, the need for low temperature storage and transportation and the 
delivery through sterile injections. Most of these expenses could be minimized or 
eliminated when therapeutic proteins are expressed and orally delivered via plant cells. 
Chloroplasts have the machinery to fold complex and biologically active 
eukaryotic proteins in the soluble chloroplast stromal compartment. Protein expression 
through chloroplast transformation system offers a number of advantages over nuclear 
transformation such as a high level of transgene expression (up to 47% of the total 
soluble protein), due to the presence of 10,000 copies of the transgene per cell, which is 
uniquely advantageous for oral delivery of adequate amounts of the therapeutic protein or 
vaccine antigen. It is also an environmentally friendly approach due to effective gene 
containment and lack of transgene expression in pollen since the chloroplast genome is 
maternally inherited. 
             To study receptor-mediated oral delivery of therapeutic proteins using the 
transmucosal carrier cholera toxin B subunit (CTB), a CTB-GFP fusion protein separated 
by a furin cleavage site was expressed via the tobacco chloroplast genome and used as a 
visible marker. Site specific integration of the transgene was confirmed by PCR analysis. 
Southern blot analysis confirmed homoplasmy. Immunoblot analysis confirmed the 
expression of both the monomeric as well as the pentameric forms of CTB-GFP in 
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transgenic plants. Expression levels of upto 21.3% were obtained and the functionality of 
the CTB-GFP pentamers was confirmed by an in vitro GM1 binding assay.  GFP was 
seen in the intestinal mucosa, liver and spleen of mice orally fed with CTB-GFP 
expressing leaves, while CTB was detected only in the intestinal cells. Intestinal 
macrophages and dendritic cells stained positive for both the CTB as well as GFP. These 
results suggest successful cleavage of the foreign protein from the transmucosal carrier 
and its delivery to various organs. These investigations should facilitate the development 
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One of the most challenging problems of human health management is the high 
cost of prescription drugs in developed countries and their lack of availability in 
developing countries. For example, interferon (IFN) alpha 2b is used for the treatment of 
viral diseases such as hepatitis C as well as for certain cancers. However, interferon 
treatment for four months costs $26,000 in the United States where more than forty five 
million Americans do not have health insurance (Daniell 2004b).  Several hundred 
million people in developing countries are infected with hepatitis but the daily income of 
one third of the world’s population is less than $2 per day (Daniell 2004b).  The high cost 
of prescription drugs is due to a number of reasons including fermentation based 
production (each fermenter costs several hundred million dollars to build), expensive 
purification and in vitro processing methods (such as column chromatography, disulfide 
bond formation costing about 60% of production cost, Petridis, 1995), the need for 
storage and transportation at low temperature and delivery via sterile injections requiring 
the involvement of hospitals and highly qualified health professionals (Daniell 2004b). 
Therefore, new approaches to minimize or eliminate most of these expenses are urgently 
needed.  
Transgenic plants to produce biopharmaceuticals 
  Transgenic plants offer many advantages over other methods of production of 
biopharmaceuticals. As discussed previously, the low cost of production of 
biopharmaceuticals due to elimination of the need for expensive purification and in vitro 
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processing reduces the prices of these products thus making them available to people who 
need them the most. Since the proteins are encapsulated in plant cells, it eliminates the 
necessity of the presence of a cold chain to get to the consumer (Daniell 2004b). 
Protection of the protein via bioencapsulation also provides heat stability (Mason 2002, 
Arntzen 2005). Plant based biopharmaceuticals are also safer since plant-derived 
products are less likely to be contaminated with human pathogenic microorganisms than 
those derived from animal cells because plants in general do not act as hosts for human 
infectious agents (Giddings 2000). The generation of systemic and mucosal immunity 
(Mason 1998) or induction of oral tolerance (Arakawa 1998) on oral delivery of 
biopharmaceuticals or vaccine antigens is another important advantage.  
Chloroplast Genetic Engineering 
The concept of chloroplast genetic engineering was first conceived in the mid 
1980’s with the introduction of isolated intact chloroplasts into protoplasts (Daniell and 
McFadden 1987). The development of the biolistics method of transformation made it 
feasible to transform plastids without the need to isolate them (Klein et al.1987).  In 
1991, the C. reinhardtii chloroplast genome was transformed with the aadA gene 
conferring spectinomycin or streptomycin resistance (Goldschmidt- Clermont 1991). This 
became a major breakthrough since different varieties of plants could be transformed 
using aadA as the selectable marker. In 1993, stable integration of the aadA gene into the 
tobacco chloroplast genome was demonstrated (Svab and Maliga 1993). Initially, when 
the transgenes were introduced via the chloroplast genome, it was believed that foreign 
genes could be inserted only into transcriptionally silent spacer regions of the chloroplast 
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genome (Zoubenko et al. 1994). The second major breakthrough came in 1998 when 
Daniell et al. (1998) advanced the concept of inserting transgenes into functional operons 
and transcriptionally active spacer regions. This approach facilitated the insertion of 
multiple genes under the control of a single promoter, enabling the coordinated 
expression of transgenes (DeCosa et al. 2001). The trnI-trnA intergenic region is 
transcriptionally active because of the read-through transcription of the upstream 16S 
rRNA promoter capable of transcribing six native genes downstream (Dhingra et al. 
2004).   
Transformation of tobacco chloroplasts 
Tobacco, a non-food/ feed crop is ideal for transformation because of its ease for 
genetic manipulation. Another advantage of tobacco is that it is an excellent biomass 
producer (in excess of 40 tons fresh leaf weight/acre based on multiple mowings per 
season) and a prolific seed producer (up to one million seeds produced per plant), thus 
making it very beneficial for large-scale commercial production of vaccines and 
therapeutic proteins. For example, one acre of cultivar can produce 400 million doses of 
anthrax vaccine (Watson et al. 2004). It has been estimated that the cost of production of 
recombinant proteins in tobacco leaves will be 50-fold lower than that of Escherichia coli 
fermentation systems (Kusnadi 1997). Tobacco has been used for hyper-expression of 
vaccine antigens for cholera (Daniell et al. 2001), anthrax (Watson et al. 2004), plague 
(Daniell et al. 2005), hepatitis C (Bhati 2005), rotavirus (Kalluri 2005), amoebiasis 
(Chebolu 2005) and tetanus (Tregoning et al. 2003). Various biopharmaceuticals such as 
human serum albumin (Fernandez et al. 2003), human somatotropin (Staub et al. 2000), 
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interferon-GUS fusion proteins (Leelavathi and Reddy 2003), magainin, a broad 
spectrum topical agent, systemic antibiotic, wound healing stimulant and a potential 
anticancer agent (Degray et al. 2001), interferon alpha (Daniell et al. 2004a), insulin and 
insulin- like growth factor (Daniell et al. 2004) have also been expressed. Monoclonal 
antibodies such as Guy’s 13, a monoclonal antibody against Streptococcus mutans which 
protects against dental carries has also been expressed in the chloroplast (Daniell et al. 
2001b). Xylanase, an industrially important enzyme, when expressed through the nuclear 
transgenic plants showed cell wall degradation and affected plant growth, while 
expression via chloroplasts showed no such effects (Leelavathi et al. 2003, Daniell et al. 
2004d).  
Introduction of agronomic traits via chloroplast engineering 
Chloroplast genetic engineering technology has been used to generate useful traits 
such as insect resistance, herbicide resistance, drought tolerance, and so on. Insect 
resistance has been achieved by expressing insecticidal proteins from Bacillus 
thuringiensis (Bt); the Cry2Aa2 protein was expressed at levels up to 47%  of total leaf 
protein which to date is the highest expressed foreign protein in transgenic plants 
(DeCosa et al. 2001). Herbicide resistance was achieved against glyphosate, a broad 
spectrum herbicide that non-selectively kills weeds by inhibiting a nuclear-encoded 
chloroplast localized enzyme, 5-enolpyruvylshikimate- 3-phosphate synthase (EPSPS), in 
the shikimic acid pathway of plants and microorganisms that is required for the 
biosynthesis of aromatic amino acids (Daniell et al. 1998). The antimicrobial peptide 
MSI-99, an analog of magainin has been expressed in the chloroplast genome of 
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transgenic tobacco up to 21.5% TSP (Degray et al. 2001). MSI-99 offers protection 
against prokaryotic organisms due to its high specificity for negatively charged 
phospholipids found mostly in bacteria. Extracts from MSI-99 transformed plants 
inhibited growth of Pseudomonas aeruginosa, a multi-drug resistant bacterium, which 
acts as an opportunistic pathogen in plants, animals and humans. MSI-99 is also 
biologically active against Pseudomonas syringae, a major plant pathogen (DeGray et al. 
2001, Devine and Daniell 2004, Daniell et al. 2004a). Drought tolerance was generated 
by expressing the yeast trehalose phosphate synthase (TSP1) gene in tobacco plants (Lee 
et al. 2003).  
Chloroplast engineering of important crops 
Chloroplast genetic engineering technology is currently applied to other useful 
crops such as potato, tomato, carrot, cotton and soybean by transforming different plastid 
genomes (Sidorov et al. 1999, Ruf et al. 2001, Kumar et al. 2004a, Kumar et al. 2004b, 
Dufourmantel et al. 2004). Successful transformation of food crops can enable the 
expression of vaccines and therapeutic proteins in these plants, making edible vaccines 
and proteins a reality. There are certain limitations to this however, such as inadequate 
tissue culture protocols, lack of selectable markers and a difficulty in expressing 
transgenes in non-green tissues (Daniell et al. 2004d).   
Carrot plastid genome has been transformed using the non-green tissue as 
explants and regenerated via somatic embryogenesis (Kumar et al. 2004a). 
Overexpression of betaine aldehyde (BA) in carrot was carried out to engineer salt 
tolerance. The toxic betaine aldehyde is converted to non-toxic glycine betaine by the 
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chloroplast BADH enzyme. Glycine betaine serves as an osmoprotectant and confers salt 
tolerance. The transgenic calli obtained from cultured cells expressing BADH are green 
in color which distinguishes them from the untransformed cells which are yellow. Since 
somatic embryos of carrot are derived from a single cell and multiply via recurrent 
embryogenesis, the resultant transgenic plant is obtained from a single source of origin. 
Carrot is also an ideal plant to be used as an edible vaccine since it can be eaten raw 
which preserves the structural integrity of the vaccine antigen.  
Other than carrot, chloroplast genetic engineering of various other plants has also 
been achieved. Kumar et al. recently transformed the cotton plastid genome. The 
transgenic seeds obtained were resistant to kanamycin selection whereas the 
untransformed seeds were not (Kumar et al. 2004b).  Similarly, the first successful 
development of transgenic soybean plants was achieved by Dufourmantel et al. 
(Dufourmantel et al. 2004). The successful plastid transformation of these crop plants 
was suggested to be due to the use of 100% homologous plastid DNA sequences in the 
species-specific vectors. Even though the concept of universal vector was proposed 
several years ago, the use of species-specific vectors has demonstrated successful plastid 
transformation (Daniell et al. 2004d).  
Advantages of chloroplast engineering over nuclear expression system 
One of the major drawbacks of the nuclear expression system is the possibility of 
transmission of the transgene to the surrounding nontransgenic plants via cross 
pollination. This is one of the primary reasons for resistance to GM crops in Europe. The 
chloroplast genome on the other hand is maternally inherited (Nagata 1995). Thus the 
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technique is environmentally safe; making chloroplast transgenic plants an excellent 
choice as biofactories to produce vaccines and biopharmaceuticals on a large scale 
(Daniell 2002). The maternal inheritance of chloroplast genome in plants is achieved 
during the male pollen development of generative cells which form the sperm cells. 
During the process of microspore mitosis, all the plastids get distributed to the vegetative 
cells and the generative cells are devoid of plastids. In some species, the generative cells 
get a few plastids which degenerate during maturation. Another type of maternal 
inheritance seen in several cereal crops occurs during the fertilization process, during 
which the sperm nucleus alone is transmitted into the egg cell while the plastid genome is 
removed either just prior to or during the process of fertilization (Hagemann 2004).      
Another drawback of the nuclear expression system is the poor levels of protein 
expressed in the plants. In order for production of proteins in plants to be commercially 
feasible, expression levels greater than 1 % of the total soluble protein must be achieved 
(Kusnadi et al. 1997). Chloroplast genetic engineering has shown a very high level of 
expression of the foreign protein (DeCosa et al. 2001), making this approach 
commercially viable for the production of biopharmaceuticals on a large scale.  The high 
expression levels are also very important when delivering vaccines orally i.e. when using 
the concept of edible vaccines, since adequate quantities of the vaccine antigen can be 
delivered due to the high expression levels. The high expression levels are due to the 
presence of 10,000 copies of the chloroplast genome in a single cell. A typical plant leaf 
cell contains about 100 chloroplasts and each chloroplast further harbors approximately 
100 copies of the same genome. This implies that a single gene is represented by at least 
 7
10,000 copies in a single plant cell. The copy correction mechanism ensures that 
introduction of the transgene into any one of the inverted repeat regions of the chloroplast 
genome gets integrated into the other region as well, thus further increasing the number 
of transgenes per cell. This makes it quite appealing to introduce a transgene into the 
chloroplast genome and obtain high levels of expression, taking advantage of the high 
copy number (Daniell et al 2004c). Unlike random nuclear integration, chloroplast 
integration is site specific. Thus the problems of gene silencing and position effect due to 
random integration of the transgene are not seen in chloroplasts. It is possible to insert a 
foreign gene into the site-specific transcriptionally active spacer region between the 
functional genes of chloroplast genome using two flanking regions via homologous 
recombination (Daniell 2001). Chloroplast transformation vectors are thus designed with 
homologous flanking sequences on either side of the transgene (Daniell et al. 1995) and 
introduced into the chloroplast genome of plant cells via particle bombardment (Sanford 
et al 1993) or into the protoplasts by the process of PEG treatment (Golds et al 1993). 
Chloroplasts also possess the ability to accumulate any foreign proteins in large amounts 
that could otherwise be harmful if they were in the cytoplasm. Trehalose, a 
pharmaceutical industry preservative was toxic when accumulated in cytosol where as 
was non toxic when compartmentalized in plastids by chloroplast expression system (Lee 
et al 2003). 
Unlike in nuclear transformation, multigene engineering in a single 
transformation event is possible in chloroplasts since chloroplasts can process 
polycistronic RNAs arranged in an operon (Daniell et al 2002). Under the control of 
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strong 16 s ribosomal RNA gene promoter (Prrn) located upstream of the transgene, read 
through transcription occurs which facilitates the transcription of the foreign gene or 
genes flanked by 3’ and 5’ untranslated regions. This approach has been highly 
successful in expressing proteins in an operon system downstream of the aadA gene after 
inserting the cassette into trnA–trnI intergenic region of the chloroplast vector (Quesada 
et al 2005). The cry operon from Bacillus thurengiensis (Bt), coding for the insecticidal 
protein delta-endotoxin, introduced into the chloroplast genome showed an expression of 
about 47% of the total soluble protein (DeCosa et al. 2001). A native bacterial operon 
without codon optimization was engineered successfully in transgenic chloroplasts. Two 
bacterial enzymes that confer resistance to two different forms of mercury poisoning 
(mercuric ion reductase (merA) and organomerurial lyase (merB)) were expressed as an 
operon in transgenic chloroplasts, and conferred resistance to very high levels of mercury 
and highly toxic organomercurial compounds (Ruiz et al 2003).  
Advantages of chloroplast engineering over E. coli expression system 
A major disadvantage of the E. coli expression system is the high cost of 
fermentors required as well as expensive in vitro processing and purification steps needed 
to properly fold and purify a transgenic protein. Recombinant proteins such as insulin for 
instance require very expensive in vitro processing which accounts for about 60% of the 
cost of production in E. coli (Petridis 1995). 
 Chloroplasts, on the other hand, have the machinery to correctly process and fold 
eukaryotic proteins in the soluble stromal compartment (Daniell 2004b).  Chaperonins 
present within chloroplast are believed to aid in the folding and assembly of non native 
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prokaryotic and eukaryotic proteins (Daniell et al 2001, Daniell et al 2005). The light 
signal sensed by chlorophyll is transferred via the photosynthetic electron flow to 
proteins called thioredoxins, which are very efficient in thio-disulfide interchanges with 
various protein disulfides (Ruelland and Miginiac-Maslow, 1999).   The Protein Disulfide 
Isomerase (PDI) system consisting of chloroplast polyadenylate-binding proteins that 
specifically bind to the 5’UTR of the psbA mRNA and are modulated by redox status 
through PDI (Kim and Mayfield, 1997), is another mechanism of control of disulphide 
bond formation.   
Another advantage of chloroplast genetic engineering over E. coli expression 
system is the ability to hyperexpress the transgene using a light regulated promoter. The 
psbA 5’UTR consists of essential light regulated translation elements that are target sites 
for enhancing the translation. The light driven photosynthetic electron transport chain 
generates an electrochemical gradient across the thylakoid membranes, the redox states of 
specific electron carriers, and stromal ADP/ATP ratio which are sensed by the translation 
regulators. These regulators aid in the binding of specific proteins to the ribosome 
binding sites of 5’UTR psbA which enhances translation (Zerges 2004). Expression of 
human serum albumin HSA under the control of psbA 5’UTR was light dependent as was 
seen by the 11.1% of tsp expression levels obtained after 50 hours of continuous light. 
There was also a 2-4 fold decrease in expression after the 8 h dark period thus 
highlighting the importance of the light regulated promoter. The levels of expression of 
HSA in mature plants under the translational control of SD sequence showed very low 
amount of accumulation when compared to expression under the control of psbA 
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promoter and 5’UTR which resulted in a 500-fold increase in HSA accumulation as 
inclusion bodies in chloroplast which probably offered protection from proteolytic 
degradation (Fernandez-San Millan A et al 2003). Similarly, expression levels of 
Interferon alpha 2b was about 19% of TSP under continuous light illumination (Daniell et 
al 2004a ). 
Vaccine antigens expressed in transgenic chloroplasts 
 Apart from the general advantages of the chloroplast expression system, there are 
several special features that make the expression of vaccine antigens via the chloroplast 
genome very attractive. 
1. Subunit vaccines are not toxic even when expressed at high levels 
2. Bacterial genes have high AT content allowing for high expression in the 
chloroplast  
3. Oral delivery of vaccines via plant cells enables the development of both 
systemic as well as mucosal immunity  
4. Expression of the vaccine antigen in the plant cell protects the antigen by 
bioencapsulation 
Vaccines that have already been expressed in the chloroplast include the Cholera 
toxin B-subunit (CTB), which does not contain the toxic component that is in CTA 
(Daniell et al. 2001a), the F1~V fusion antigen for plague (Singleton 2003), the 2L21 
peptide from the Canine Parvovirus (CPV) (Molina et al. 2004), Anthrax Protective 
antigen (PA) (Watson et al. 2004), C terminus of Clostridium tetani (TetC) (Tregoning et 
al. 2003), LecA for Entamoeba histolytica (Chebolu 2005), NS3 for hepatitis C (Bhati 
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2005), NSP4 for rotavirus (Kalluri 2005). The functionality of these vaccine antigens was 
determined by both in vitro assays as well as in vivo studies. CTB for instance was 
effective in the GM1-ganglioside binding assay which indicates proper folding and 
formation of disulfide bonds to form pentamers (Daniell et al. 2001a). When mice were 
immunized intraperitoneally with the leaf extracts from chloroplast expressed CTB-2L21, 
the developed anti-2L21 antibodies were able to recognize VP2 protein from CPV 
(Molina et al. 2004). Anthrax PA83 expressed in transgenic tobacco chloroplasts elicited 
an immune response in the mice proving that plant derived PA is biologically similar to 
PA derived from Bacillus anthracis (Koya 2004). The C terminus of Clostridium tetani 
(TetC) was expressed at 25% TSP for AT rich and 10% TSP for GC rich sequences 
which shows that chloroplasts favor prokaryotic-AT rich sequences. TetC when 
administered intranasally produced both IgG and IgA antibodies and was 
immunoprotective against the toxin (Tregoning et al. 2003).  
Bioencapsulation for protection of vaccine antigens in plant cells 
Oral delivery of vaccines and biopharmaceuticals is essential for development of 
mucosal immunity as well as induction of tolerance. It also serves as a cost effective 
means of protein delivery eliminating the need for expensive in vitro processing, 
purification, cold chain and sterile injections. Plant cells provide the ideal vehicle for oral 
delivery primarily due to the phenomenon of bioencapsulation. The vaccines and 
therapeutic proteins are protected inside the cell wall of the plant cell hence preventing 
degradation by the stomach acid pH and digestive enzymes (Walmsley and Arntzen 
2000, Yu and Langridge 2001). In the intestine, certain enzymes such as alpha,beta 
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hydroxylases create pores in the cell wall enabling the release of the transgenic protein 
into the intestinal lumen allowing for successful oral delivery. In human clinical trials 
performed with plant derived vaccines, plant cells have proven sufficient for vaccinogen 
protection against digestion, and the vaccinogen has induced systemic and mucosal 
immune responses without the aid of adjuvants (Tacket et al. 1998, Kapusta et al. 1999, 
Tacket et al. 2000, Walmsley and Arntzen 2000, Tacket et al. 2003, Tacket et al. 2004). 
Heat-labile enterotoxin B-subunit (LTB) from E. coli was expressed by nuclear 
transformation in tobacco (<0.01% Total soluble protein) and potato (0.19% TSP). The 
LTB expressed in potato was found to be immunoprotective when administered orally. 
Inspite of lower expression in tobacco these antigens were immunogenic (Haq et al. 
1995, Mason et al. 1996, Tacket et al. 1998). The capsid protein of the Norwalk virus 
expressed in potato and tomato was immunogenic when administered orally (Mason et al. 
1996, Richter et al. 2000, Tacket et al. 2000). The envelope surface protein of hepatitis B 
virus was expressed by nuclear transformation in tobacco, potato and lupin. They all had 
less than 0.01% fresh weight expression but were still immunogenic (not protective) 
when administered orally (Richter et al. 2000, Kapusta et al. 1999). This again brings us 
to the need to ensure high expression of therapeutic proteins in plants. IFN-alpha given 
orally has biological activity in humans and other animals (Bocci 1999). Plant derived 
edible vaccines have also been proven in commercial animal and native animal trials 
(Castanon et al. 2000, Tuboly et al. 2000). Chloroplast genetic engineering is currently 
being applied to crops amiable to oral vaccines such as potato, tomato, carrot and 
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soybean (Sidorov et al. 1999, Ruf et al. 2001, Kumar et al. 2004a, Dufourmantel et al. 
2004). 
CTB as a transmucosal carrier to orally deliver biopharmaceuticals   
Cholera toxin (CT) belongs to the AB5 family of toxins and consists of an A subunit and 
a pentameric B subunit. Cholera toxin B subunit (CTB) is a non-toxic part of the 
enterotoxin produced by Vibrio cholerae, which causes acute watery diarrhea (rice water 
stools). CTB is a homo-pentamer of 5 identical subunits of 11.6 KDa that form a ring like 
structure and have the ability to bind selectively to oligosaccharide GM1 ganglioside 
receptors present on the intestinal epithelial cell surfaces (Sixma et al. 1991, 1992; 18 
Lencer, 2001). GM1 sorts the CT into lipid rafts and via a retrograde trafficking pathway 
to the endoplasmic reticulum, where the toxin unfolds and transfers its enzymatic subunit 
(CTA) to the cytosol, probably by translocation through the translocon sec61P (Lencer, 
2001).  CTB bound to the receptor GM1  exits the ER and remains membrane bound in 
the basolateral surface of the cell. In this manner, CTB delivers a macromolecule 
conjugated to it across the intestinal lumen into the intestinal cell.  CTB is also known to 
act as a mucosal adjuvant which enhances the antibody response when coadministered 
with unrelated antigens and increase antibody titers (Northrup and Fauci, 1972, Richards, 
2001, Millar et al. 2001, Salmond et al. 2002). 
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RATIONALE AND APPROACH 
The aim of this project was to create an efficient delivery mechanism for the oral 
delivery of therapeutic proteins expressed in transgenic chloroplasts. For this proof-of-
concept project GFP was chosen as a visible marker. Since the chloroplast expression 
system has several unique advantages as discussed above, the method was selected to 
transform tobacco chloroplasts. CTB was chosen as a transmucosal carrier to efficiently 
deliver proteins across the intestinal lumen.  
Accordingly, a CTB-GFP fusion protein, separated by a furin cleavage site, was 
expressed in tobacco chloroplasts. Furin, a member of prohormone-proprotein 
convertases
 
(PCs Van den Ouwenland et. al,. 1990, Nakayama 1997) is a ubiquitously 
expressed enzyme found in the trans-Golgi network (TGN Bosshart et al.1994, Molloy 
1994), endosomes, plasma membrane and extracellular space (Mayer 2004). Furin 
cleaves protein precursors with narrow specificity following basic Arg-Xaa-Lys/ Arg-
Arg-like motifs (Henrich et al. 2003). The furin cleavage site between CTB and GFP 
would therefore facilitate intracellular cleavage of the target protein (GFP), thus enabling 
the delivery of the GFP across the intestinal cell into the circulation.  
The CTB-furin-GFP transgene cassette was cloned into the universal chloroplast 
vector pLD-Ctv which has flanking regions from the tobacco chloroplast genome to 
enable homologous recombination. The resultant leaves of the transgenic plants were fed 
to female Balb/c mice which were then sacrificed. The liver, spleen and intestine of the 
mice were examined for the presence of GFP. To judge the efficiency of the transmucosal 
carrier, transgenic leaves expressing another construct, IFN-furin-GFP were also fed to 
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another group of Balb/c mice, which were also sacrificed. The liver, spleen and intestine 
of these mice were examined as well. As a negative control, untransformed leaves were 
fed to a third group of Balb/c mice.  
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MATERIALS AND METHODS 
General Protocols 
The ultra competent cells were prepared using rubidium chloride method (Kumar 
et al. 2004). The ultra competent cells are absolutely necessary for the transformation of 
bacterial cells with the plasmid. E.coli XL1-Blue MRF ab (Stratagene), a disabled non 
pathogenic, tetracycline resistant strain, has a history of safe laboratory use due to its 
inability to survive in the antibiotic environment and has been used to prepare the ultra 
competent cells. The E.coli glycerol stock was streaked on the LB agar plate containing 
12.5 µg/ml tetracycline and incubated at 37 °C overnight. Single isolated colony was 
picked and grown in 5 ml of Psi broth (per liter- 5g Bacto yeast extract, 20g Bacto 
Tryptone, 5g magnesium sulfate, pH 7.6) containing 12.5 µg/ml tetracycline and 
incubated at 37 °C for 12- 16 hrs in a horizontal shaker at 225 rpm. Approx. 1 ml of the 
overnight culture was inoculated in 100 ml of Psi broth and was incubated at 37 °C for 
about 2 hours in a shaker at 225 rpm. The optical density (O.D) was checked at 550 nm 
after two hours and subsequently after each half hour or an hour depending on the O.D 
value. The culture was continued to grow until it reaches to 0.48 O.D. The culture was 
kept on ice for 15 minutes. The cells were pelleted by centrifugation at 3000g/5000 rpm 
for 5 minutes in a sorvall centrifuge. The supernatant was discarded and the pellet was 
resuspended in 0.4 volume (40 ml) of ice-cold TFB-I solution. The cells were re-pelleted 
at 3000g / 5000 rpm for 5 minutes. The supernatant was discarded and the cells were 
resuspended in (0.04 volume) 4 ml of TFB-II solution and immediately iced for 15 
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minutes. This suspension was divided into 100 µl aliquots, then quick frozen in liquid 
nitrogen and stored at - 80 °C. 
Transformation of the Competent E. coli XL1-Blue cells 
The competent cells of one hundred µl aliquot were taken from -80 °C and 
immediately thawed on ice and transferred to a falcon tube. About one µl (100 ng) of 
plasmid DNA was added to the competent cells and was mixed by gentle tapping. The 
mixture was incubated on ice for 30 minutes with gentle tapping at after first 15 min. 
Then, the mixture was incubated at 42° C in a water bath for 90-120 seconds and then 
immediately put on ice for two minutes. Approx. 900µl of LB broth was added to cells 
and were incubated at 37° C for 45 minutes in a horizontal shaker at 225 rpm. The cells 
were pelleted by spinning at 13,000 rpm for 30 seconds. The eight hundred µl of 
supernatant was discarded leaving 100µl, followed by resuspending the cells. Two 
samples, 50µl and 100µl, of the suspension were inoculated on the agar plate with 
appropriate selection agent and spread with a glass rod. 
Construction of chloroplast vector 
The pLD-CTB-GFP construct was based on the universal chloroplast vector pLD 
(Fig.1) that has been used successfully in this laboratory (Daniell 2001a). CTB-GFP 
construct was engineered with a furin cleavage site, Pro-Arg-Ala-Arg-Arg, in between 
CTB and GFP. The constitutive 16 s rRNA promoter was used to drive transcription of 
the aadA and the CTB-GFP genes. The aminoglycoside 3’adenylyltransferase (aadA) 
gene conferring spectinomycin resistance was used as a selectable marker. The 5’-UTR 
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from psbA, including its promoter, was engineered to enhance translation of the CTB-
GFP since it has several sequences for ribosomal binding sites. The 3’UTR region 
conferred transcript stability. 
Bombardment and selection of transgenic plants 
The Bio-Rad PDS-1000/He biolistic device was used to bombard pLD-CTB-GFP 
onto sterile Nicotiana tabacum cv. Petit Havana tobacco leaves, on the abaxial side as has 
been previously described (Daniell 1997). The bombardment media was prepared as 
described previously (Daniell 1997). For the bombardment, it is most important to 
maintain the aseptic conditions. For this all the essential equipments were sterilized. The 
stopping screens, macro carrier holders, forceps, Whatman filter paper, Kim wipes were 
autoclaved prior to bombardment. The macro carriers and the rupture discs were 
sterilized under hood by immersing them in 95% ethanol for 15 minutes followed by 
drying. Fifty µl of gold particles was placed in a micro centrifuge tube and 10 µl of DNA 
(1 µg/µl) were added. Fifty µl of 2.5M CaCl2, 20 µl of 0.1M spermidine-free base were 
added sequentially to the mixture to ensure proper binding of DNA to the gold particles. 
Vortexing was done after addition of each component to ensure proper mixing of 
components and binding of DNA to the gold particles. The mixture was then vortexed for 
20 minutes at 4 °C. Two hundred µl of absolute ethanol was added to the vortexed 
mixture at room temperature and followed by a quick spin at 3000 rpm in a microfuge for 
30 seconds, supernatant was removed and this wash procedure was repeated four times. 
Finally, the gold particles were resuspended in thirty ul of 95% ethanol. The gold 
particles with DNA were placed on ice to be used in next two hours. Aseptic green 
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healthy leaves from Nicotiana tabacum var. Petit havana plant growing in jars containing 
MSO medium (30g sucrose, 1 packet of MS basal salt mixture, pH 5.8) and placed on a 
petri dish (100 x 15) containing RMOP media with no selection and a Whatman filter 
paper on the top of media. The RMOP media contains MS basal salt mixture (one pack), 
30 grams of Sucrose, 100mg of myo-inositol, 1ml of benzylaminopurine (BAP: 1mg/ml), 
100 µl of α -naphthalene acetic acid (NAA: 1mg/ml), 1ml of thiamine hydrochloride 
(1mg/ml), and Water (1 liter), with the pH adjusted to 5.8 using 1N KOH. About six 
grams of phytagar per liter was added to the media and autoclaved. The leaves were 
placed with the abaxial side upwards. The gene gun (Bio-Rad PDS-1000/He) was 
sterilized in the inside chamber with 70% ETOH prior to bombardment. The macro 
carriers were placed on the macro carriers holders. The gold particles lying on ice were 
vortexed and five µl of gold particles containing the DNA were placed on top of the 
macro carrier. Vortexing is an important step while placing the gold particles on the 
macro carriers. The rupture disc, stopping screens and macrocarrier holders containing 
the macrocarrier, and the leaf were put in place and secured to proceed with the 
bombardments. The gene gun and the vacuum pump were turned on, and the helium tank 
was turned to the open positions and the valve is turned on till the pressure reaches 1350 
psi. The vacuum in the gene gun was allowed to build to 28 psi, and was then held briefly 
and then fired (the fire switch was held until the rupture disk broke at ~1100 psi). After 
the bombardment, the vacuum was released, and the petri dish with the leaf was taken out 
and covered. After the samples were finished they were covered with aluminum foil (to 
keep them dark) and incubated for 48 hours at room temperature (Kumar and Daniell 
 20
2004). The bombarded leaves were incubated in the dark for 24 hours and then placed on 
shooting media (RMOP) containing 500 µg/ml spectinomycin for two rounds of 
selection. 
PCR analysis to test stable integration 
DNA was isolated using Qiagen DNeasy Plant Mini Kit, from the transgenic 
shoots and PCR analysis was performed to confirm integration of the transgene in the 
inverted repeat regions of the chloroplast genome. DNA from a known transgenic plant 
was used as a positive control while DNA from a wild type Petit Havana plant was used 
as a negative control. To confirm integration of the transgene cassette into the chloroplast 
genome, PCR analysis was carried out using the primers 3P (5’ 
GGAATTGAATTCCATATGTGTGAGAACAGA3’) and 3M (5’ 
AGAATTGCCTCTAGACTATTCTGAAAC 3’). To confirm integration of the gene of 
interest into the chloroplast genome the primers 5P 
(5’ATGTAGAAGTCACCATTGTTGTGC-3’)and2M(5’-GACTGCCCACCTGAGAGC-
GGACA-3’) (Daniell et. al, 2001a) were used. The samples were denaturated for 5 mins 
at 95◦C followed by 30 cycles of the following temperatures: 95 ◦C for 1 min, 65 ◦C for 1 
min, and 72 ◦C for 2 min and a 72◦C hold for 10 min after all 30 cycles were completed. 
After confirmation of transgenic plants, the shoots were then transferred to a rooting 
medium (MSO) with 500 µg/ml spectinomycin as a selective agent. 
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Southern blot analysis 
Total plant DNA from different lines of transgenic plants and one wild type plant 
was digested overnight with EcoR1, separated on a 0.7% agarose gel at 45V for 8 hours. 
The gel was then depurinated by immersing it in 0.25M HCl (depurination solution) for 
15 minutes (until the color of the dye became yellow), washed twice in dH2O for 5 
minutes, and then equilibrated in transfer buffer (0.4N NaOH, 1M NaCl, filled to 1 liter 
with water) for 20 minutes. The DNA was transferred overnight to a nitrocellulose 
membrane. The next day the membrane was washed with 2X SSC (3M NaCl, 0.3M Na 
Citrate, H2O, the pH was adjusted with 1N HCl to 7 and water was added to 1L) for 5 
minutes. Following, the membrane was allowed to dry on a Whatman paper for 5 minutes 
and then cross-linked using the Bio-Rad GS Gene Cross Linker at setting C3 (150 m 
joules). pUC-CT vector DNA was digested with BamHI and BglII to generate a 0.8 kb 
probe which was used as a flanking probe as it contains the chloroplast flanking 
sequences for the trnI and trnA.  (Daniell et al, 2005). GFP from pLD-CTB-GFP was 
used as a gene specific probe. After labeling the probe with P32, hybridization of the 
membranes was done using Stratagene QUICK-HYB hybridization solution and protocol 
(Stratagene, La Jolla, CA). The membrane was washed twice as follows: 50ml of wash 
solution number 1 (2X SSC and 0.1% SDS) was poured and incubated at room 
temperature for 15 minutes. The liquid was discarded in the liquid waste container and 
the step was repeated. A second round of washes was performed twice by pouring 50ml 
of solution number 2 (0.1X SSC and 0.1% SDS) and incubating it for 15 minutes at 60 °C 
to increase the stringency. The liquid of these washes were discarded into the radioactive 
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liquid container. The membranes were placed into the plastic wrap, placed in the film 
cassette and then taken to the dark room. Using the safe light (red light), the X-ray film 
was placed into the cassette on top of the blot and the intensifier screen was placed on top 
of the X-ray film. The cassette with the blot and the film was placed into a black bag to 
protect against light and then incubated overnight at –80 °C. The next day the cassette 
was taken out from the –80 °C, allowed to thaw, and then moved to the dark room where 
the film was developed. 
Western blot analysis 
Approximately 100 mg of leaf tissue was ground in liquid nitrogen and 
resuspended in 500 µl of plant extraction buffer (0.1% SDS, 100mM NaCl, 200mM Tris–
HCl pH 8.0, 0.05% Tween 20, 400mM sucrose, 2mM PMSF). After centrifugation at 
13,000 rpm for 5 minutes, the supernatant containing the extracted protein was collected. 
10 µl of the plant extract along with 10 µl of sample loading buffer containing BME were 
boiled, and then run on a 15% SDS–PAGE gel for 40 mins at 50V and then 2 hours at 
80V. Unboiled samples along with samples loading buffer without BME were also 
loaded. The protein was then transferred to nitrocellulose membrane for 1 hour at 80V. 
After blocking the membranes with PTM (1×PBS, 0.05% Tween 20, and 3% dry milk) 
for 1 hour, rabbit anti-CTB primary antibody (Sigma) was added. Goat anti-rabbit IgG 
conjugated to alkaline phosphatase (Sigma) was used as a secondary antibody. The 
membranes were washed with PBS (140mM NaCl, 2.7mM KCl, 4mM Na2HPO4, and 
1.8mM KH2PO4, pH 7.2) and the chemiluminescent substance was added. Later the X-
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ray films were exposed to chemiluminescence and the films were developed in the film 
processor to visualize the bands.  
Furin Cleavage Assay 
Approximately 100 mg of leaf material was powdered in liquid nitrogen and 
resuspended in 500 µl of plant extraction buffer containing 15mM Na2CO3, 35mM 
NaHCO3, 3mM NaN3, 5 mM CaCl2, 0.5% Triton-X, 2-mercaptoethanol at pH 6.0 and pH 
7.0. 1mM PMSF was added to some of the samples. After centrifugation at 13,000 rpm 
for 5 minutes, the supernatant containing the extracted protein was collected. The extract 
(20 µl) was incubated at 30°C for 4 h with 4 units of furin. A control group was also 
incubated at 30°C for 4 h without furin. After 4 hours, each sample was mixed with 20 µl 
sample loading buffer, boiled, and run on 12% SDS-PAGE gel for 45 minutes at 80V and 
then 2 hours at 100V. The Western blot analysis was performed as per the procedure 
outlined above. Chicken anti-GFP antibody (Chemicon) at a 1:3000 dilution was used as 
the primary antibody and alkaline phosphatase conjugated rabbit anti-chicken IgG 
(Chemicon) at a dilution of 1:5000 was used as a secondary antibody.  
Estimation of total soluble protein 
The total soluble protein of the leaf samples was estimated using the Bio-Rad 
Bradford Protein Assay. Leaf samples of transformed and untransformed plants (100 mg) 
were powdered in liquid nitrogen and resuspended in plant protein extraction buffer 
(15mM Na2CO3, 35mM NaHCO3, 3mM NaN3, pH 9.6, 0.1% Tween20, and 5mM 
PMSF). The standard curve was obtained by diluting Bovine Serum Albumin in plant 
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extraction buffer. 10 µl of each standard and sample were mixed with 200 µl of Diluted 
(1:4) Biorad dye reagent, loaded in microtiter plate wells, incubated at room temperature 
for 10 min and read on a plate reader at 630 nm. 
ELISA 
The CTB-GFP quantification was done using the enzyme linked immunosorbent 
assay (ELISA). The standards and test samples were diluted in coating buffer (15mM 
Na2CO3, 35mM NaHCO3, 3mM NaN3, pH 9.6). The standards, ranging from 20 to 320 
ng, were made by diluting recombinant GFP in 1% PBS. The leaf samples were collected 
from plants exposed to regular lighting pattern (16 h light and 8 h dark), and protein was 
extracted using the plant protein extraction buffer described above. 100 µl of standard 
GFP dilutions and protein samples were bound to a 96-well plate overnight at 4°C. The 
background was blocked with fat-free milk in PBST for 1 hour at 37°C followed by 
washing with PBST and water. Primary antibody used was chicken anti-GFP antibody 
(Chemicon) diluted (1:3000) in PBST containing milk powder. Secondary antibody was 
HRP-conjugated rabbit anti-chicken IgG- secondary antibody (Chemicon) at a 1: 5000 
dilution in PBST containing milk powder. For the color reaction, 100 µl of 3,3_,5,5_-
tetramethyl benzidine (TMB from American Qualex) substrate was loaded in the wells 
and incubated for 10–15 min at room temperature. The reaction was stopped by addition 
of 50 µl of 2N sulfuric acid per well and the plate was read on a plate reader (Dynex 
Technologies) at 450 nm. 
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GM1binding assay 
To test the functionality of CTB-GFP expressed in chloroplasts, a CTB-
GM1binding assay was performed. 96 well plates were coated with 100 ul of 
monosialoganglioside- GM1 (Sigma) (3.0 µg/ml in ELISA coating buffer) and incubated 
overnight at 4oC. After washing with PBST and water, the standards and samples were 
incubated for 1 hour at 37oC.  The plate was blocked with 1% BSA in 1X PBS for 1 hour 
at 37oC. Rabbit anti-CTB primary antibody (Sigma) and alkaline phosphatase (AP) 
conjugated goat anti-rabbit secondary antibody (Sigma) was used to detect the CTB 
binding to GM1 receptor. The plates were washed with PBST and water, and 200 µl of the 
substrate PNPP was added to the wells and incubated in the dark at 37oC for 20 minutes. 
The reaction was stopped by adding 50 µl of 3N NaOH and the plates were read on a 
plate reader (Dynex Technologies) at 405 nm.     
Animal studies 
Three groups of five week old female Balb/c mice were fed with CTB-GFP, 
Interferon alpha2B-GFP (IFN-GFP) and wild type (untransformed) plant leaf material. 
350 mg of leaves were powdered in liquid nitrogen, mixed with peanut butter and fed to 
the mice which had been starved over night prior to this experiment. The mice were then 
gavaged for two more days, two times a day with 40 mg of leaf material per gavage, 
powdered with liquid nitrogen and mixed with 0.1M phosphate-buffered saline (PBS). 
Five hours after the last gavage the mice were sacrificed and perfused with 10 ml of PBS 
followed by 4% paraformaldehyde in PBS. Fresh frozen sections of the liver, spleen, 
ileum and jejunum were collected according to Samsam et al., (2003).  Additional tissue 
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was removed and immersed in Tissue Tec freezing medium (Vector labs) and 
immediately frozen in nitrogen cooled isomethylbuthane (isopathane, Sigma). Fixed 
tissue was cryoprotected by passing through 10%, 20% and 30% sucrose solutions in 
PBS. Ten micrometer (µm) thick frozen sections of various tissues were then made using 
a cryostat. 
Immunohistochemistry for GFP, CTB and immune cells 
Immunohistochemistry was performed in order to show the presence of GFP 
and/or CTB in various tissues. The slides were first blocked with 10% BSA (bovine 
serum albumin) and 0.3% Triton-X 100. Chicken anti-GFP (Chemicon) or rabbit anti-
CTB (Sigma) primary antibodies, at a concentration of 1: 500 and 1: 300 respectively in 
1% BSA and 0.3% Triton-X, were used for GFP or CTB localization of the tissues. Those 
sections processed for HRP conjugated secondary antibodies were blocked with a 
mixture of Methanol / Hydrogen peroxide 30% (2:1 ratio) to block the endogenous 
peroxidases. The secondary antibodies were horseradish peroxidase (HRP) -conjugated 
anti-chicken IgG (Chemicon), or HRP-conjugated goat anti rabbit (Sigma). Tissue bound 
peroxidase was developed using the 3,3’ diaminobenzidine (DAB) as a substrate to 
visualize the immunoreaction.  
For macrophage localization of the tissues, rat monoclonal F4/80 antibody 
(Serotec) was used according to Berghoff et al., 2005. The secondary antibody was Alexa 
555 conjugated Goat anti rat IgG (Molecular Probes). American hamster anti CD11c 
primary antibody and anti-hamster Alexa 546 conjugated secondary antibody (Molecular 
Probes) were used to visualize dendritic cells in the intestine and other tissues. FITC 
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labeled anti-chicken IgG was used as a secondary antibody in such immunofluorescence 







GFP expression in transgenic plants 
Figure 1 shows the transgenic and wild type plants. In B, the GFP expression of 
the transgenic plants can be seen under the UV light, which is not seen in the wild type 
(untransformed) plant (fig. 1A).  Figure C shows wild type plant and D, the CTB-GFP 
expressing plant under a low magnification fluorescent microscope. Expression of GFP is 
clearly evident in D. 
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Figure 1: GFP expression in transgenic plants: 
(a) Wild type (untransformed) plant seen under UV light. 
(b) CTB- GFP expressing leaf showing fluorescence observed under UV light. 
(c) Wild type leaf under a low magnification microscope.  





Confirmation of transgene integration into chloroplast genome 
Nicotiana tabacum cv. Petit Havana leaves were bombarded with the pLD-CTB-
GFP vector and the leaves were grown on selective medium containing 500 mg/l 
spectinomycin. The resultant shoots could be chloroplast transformants, nuclear 
transformants or spontaneous mutants.  Spontaneous mutation of the 16S rRNA gene, 
which confers resistance to spectinomycin in the ribosome, could allow plants to grow on 
spectinomycin without integration of the gene cassette which will result in the mutant 
shoot growth. The aadA gene in the gene cassette confers resistance to spectinomycin and 
hence the shoots with the integration of the gene cassette in either nuclear or chloroplast 
genome grow on the selection medium. True chloroplast transformants were 
distinguished from nuclear transformants and mutants by PCR analysis.The 3P primer 
lands on the native chloroplast genome upstream of the site of integration in the 16srRNA 
region, and the 3M primer lands on the aadA transgene producing a 1.65kb PCR product. 
This analysis ruled out the nuclear transformants since 3P primer would not anneal and 
the spontaneous mutants since 3M primer would not anneal. 
To check for the presence of the transgene in the chloroplast, the 5P-2M PCR 
analysis was performed. The 5P primer lands on aadA gene and the 2M lands on the trnA 
coding sequence producing a 2.9kb PCR product with CTB-GFP. This confirmed the 






















  1        2     3       4       5        6       7      8    1        2      3       4       5       6       7      8 
2.9 kb 











Figure 2: PCR analysis for the confirmation of transgene integration: 
(a) Schematic representation of the transgene cassette. 
(b) 5P/2M – These primers land on the aadA and trnA regions (flanking the CTB-
GFP). A 2.9 kb PCR product was obtained from the PCR analysis of trasgenic 
plants.  
(c) 3P/3M – The 3P primer lands on the native chloroplast genome and the 3M 
primer lands on the aadA gene. A 1.6 kb PCR product was obtained from the PCR 
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anlysis of the transgenic plants. Lane 1: 1kb plus ladder, Lanes 2-5: Transgenic 
lines of CTB-GFP, Lane 6: Positive Control, Lane 7: Empty, Lane 8: Wild Type 
Plant.  
Southern blot analysis to investigate homoplasmy 
To further confirm the integration of the transgene into the chloroplast genome 
and to determine if homoplasmy had been achieved, Southern blot analysis was 
performed. Total plant DNA was digested with the enzyme EcoRI and hybridized with a 
chloroplast flanking sequence probe (0.8kb). Wild type plants generated a 4.4 kb 
fragment and transgenic plants generated a 4.9 and a 2.2 kb fragments (Fig. 1D). All of 
the transgenic lines tested appeared to be homoplasmic (within the levels of detection) 
which means that all of the chloroplasts in the plant contained the transgene CTB-GFP. 
Total plant DNA digested with EcoRI was also hybridized with a gene specific probe 
(GFP). A 4.9 kb fragment was detected in the transgenic samples confirming the correct 
integration of the entire transgene in the correct spacer region in the chloroplast genome. 
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Figure 3A: Southern blot analysis  
(a) Southern blot analysis with flanking sequence probe. Lane 1: Wild-type showing 
4.4 kb fragment, Lane 2 - 5: Transgenic plants showing 4.9 and 2.2 kb 
hybridizing fragments.   
(b) Southern blot analysis with gene specific GFP probe. Lane 1 – 4: Transgenic 
plants showing 4.9 kb fragment, Lane 5: Wild type plant 
 33
Immunoblot analysis of transgenic plants 
Western blot analysis was performed to investigate the expression of the fusion 
protein CTB-GFP in transgenic tobacco chloroplasts (Fig. 4) using anti-CTB antibody. 
The pentameric form (188 kDa) was observed in the unboiled samples of the transgenic 
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Figure 4: Immunoblot analysis of CTB-GFP using anti-CTB antibodies 
Lane 1: Unboiled crude extract of transgenic line A, Lane 3: boiled crude extract of 
transgenic line A, Lane 5: Unboiled crude extract of transgenic line B, Lane 6: Boiled 
crude extract of transgenic line A, Lane 8: Purified CTB standard 200ng, Lane 9: Wild 
type plant crude extract, Lane 2, 4, 7: empty. 
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Furin Cleavage Assay 
The protease furin is present in the constitutive secretory pathway and on the cell 
surface of virtually all cells. An in vitro furin cleavage assay was performed on the CTB-
GFP expressing plant extract to show that the engineered cleavage site (Arg-Ala-Arg-
Arg) was recognized by furin. As seen in Fig. 5, a 26 kDa polypeptide that corresponded 
with the recombinant GFP protein was observed in the samples that were incubated with 
furin, thus proving that furin was able to cleave CTB-GFP to release GFP. Furin cleavage 
occurred at both pH 6.0 and 7.0 in the samples with and without PMSF. There was still 
some protein that did not get cleaved, probably because the amount of enzyme was not 
sufficient to cleave all the CTB-GFP protein present in the plant extract. The incubation 
time of 4 hours may also have been insufficient. However, the presence of the cleaved 
GFP product in the samples incubated with furin confirms that the engineered furin 
cleavage site is functional. The introduction of furin consensus sequences at the B-
chain/C-peptide and the C-peptide/A-chain interfaces of human proinsulin has been 
demonstrated to increase the processing of proinsulin to mature insulin in a wide variety 
of non-neuroendocrine cells, including fibroblasts, myoblasts, epithelial cells, and 
lymphocytes. As furin cleavage site is also recognised by the endopeptidases PC2 and 
PC3/1, it is likely that CTB-GFP fusion protein is cleaved more efficiently during the 
process of receptor mediated delivery.   
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Figure 5: Furin Cleavage Assay 
 
Lane 1: Marker, Lane 2: CTB-GFP pH 6.0 with furin, no PMSF, Lane 3: CTB-GFP no 
incubation, no furin, Lane 4: CTB-GFP pH 6.0 with furin and PMSF, Lane 5: CTB-GFP 
pH 7.0 with furin and PMSF, Lane 6: CTB-GFP pH 6.0 with PMSF, no furin, Lane 7: 
CTB-GFP pH 6.0 no PMSF, no furin, Lane 8: Blank, Lane 9: GFP standard 
 
 
Quantification of CTB-GFP 
To quantify the amount of CTB-GFP fusion protein in transgenic tobacco leaves, 
enzyme linked immunosorbent assay (ELISA) was performed (Fig. 6). A standard curve 
was obtained using different concentrations of recombinant GFP (Vector Labs). The 
amount of CTB-GFP in the transgenic plants was compared to the known concentrations 
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Figure 6. Quantification of CTB-GFP fusion protein expression levels in transgenic 
plants. 
Expression levels in % total soluble protein (TSP) of CTB-GFP expressed in 
different transgenic lines. The CTB-GFP expression ranged from 19.09% to 21.3% of 
TSP. 
GM1binding assay 
The functionality of chloroplast derived CTB-GFP was determined by its ability 
to bind to GM1 in an in vitro GM1binding assay (Fig. 7). Quantification with GM1binding 
assay showed that pentamers of CTB-GFP were formed and expressed at levels of up to 
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3.5% of the total soluble protein in plants grown under natural light in the greenhouse and 
2% in plants grown under artificial light in growth chambers. This confirms the correct 
folding and disulfide bond formation of CTB pentamers within transgenic chloroplasts 






















Figure 7. GM1 binding assay of CTB-GFP expressed in transgenic chloroplasts 
Absorbance of CTB-GFP plant extract bound to GM1 as compared with absorbance of 
BSA and wild type plant extract. 
Fluorescent microscopy to detect the presence of GFP in the tissue 
Fixed tissue and fresh frozen sections of the liver, spleen, ileum and jejunum were 
made from the three groups of mice. Fluorescence microscopy showed the presence of 
GFP in intestinal mucosa and submucosa (Fig. 8A), as well as in the hepatocytes of the 
liver (Fig. 8D) of mice fed with CTB-GFP expressing plant leaf material. GFP was also 
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detected in various cells of the spleen of mice fed with CTB-GFP expressing plant leaf 
material (fig 8G).  
In the mice fed with wild type (untransformed) leaf material, no GFP fluorescence 
was seen (Fig 8 B, E and H). In the mice fed with IFN-GFP expressing plant leaf 
material, no GFP was detected in the liver or spleen (Fig 8 F and I). In a few sections of 
the intestinal of IFN-GFP treated animals, some GFP was detected in both mucosa and 
submucosa (fig. 8C). Although GFP was transported across the lumen of the intestine 
probably via the M cells, it could not reach organs such as the liver or the spleen. This 
suggests that it is the transmucosal carrier which is responsible for the delivery of GFP 
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Figure 8: Cryosections of the intestine and liver of the mice fed with CTB-GFP or 
wild type plant leaves material.  
(a) GFP in the ileum of a mouse following oral delivery of the CTB-GFP expressing 
plant leaf material. Arrows show numerous columnar cells of the intestinal mucous 
membrane which have up-taken the CTB-GFP. Various cells in the connective tissue 
beneath the epithelium also show the presence of GFP. 












(c) Section of the ileum of a mouse fed by the IFN- GFP leaf material. 
(d) GFP in hepatocytes of a mouse liver following oral delivery of CTB-GFP expressing 
tion of the liver of a mouse fed by IFN- GFP expressing plant material.  
 expressing plant. 
- GFP expressing plant material. 
Immunohistochemistry 
In order to confirm the fluorescent microscopy findings, immunostaining was 
performed with both CTB and GFP  of the mice fed with CTB-
GFP, a
plant. 
(e) Section of the liver of a mouse fed by the wild type plant material.  
(f) Sec
(g) GFP in the spleen of a mouse following oral delivery of CTB-GFP
Arrows show various splenic cells with GFP.  
(h) Section of the spleen of a mouse fed by the wild type plant material.  
(i) Section of the spleen of a mouse fed by IFN
 Scale bar: 50 µm 
 antibodies. In the intestine
nti-GFP antibody detected GFP inside the epithelial cells of the villi of the 
intestine, in the crypts, as well as in the submucosal tissue (Fig. 9 a,b,c) suggesting GFP 
uptake by lymphoid cells as well as the circulation. These results confirmed the previous 
microscopy findings (Figure 8) and showed the presence of GFP in various tissues, 
confirming that GFP was successfully delivered to blood when transgenic leaf material 
was orally fed to the mouse. GFP immunoreactivity was detected in the liver and spleen 
(Fig. 9 e,g)  in a similar pattern to that seen with fluorescence microscopy of the native 
tissue (Fig. 8 d,g). In the case of the mice fed with wild type leaf material, no GFP was 
detected in any of the tissues (Fig. 9 f,h). In the mice fed with plants expressing IFN-
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GFP, GFP was not detected in the liver or spleen cells. These results support the 
hypothesis that CTB can act as a transmucosal carrier, and orally deliver fused proteins 





































Figure 9: Immunohistochemical localization of the GFP in mouse ileum, liver and 
spleen. 
 (a), (b) and (c) are sections of the ileum of the mice fed with CTB-GFP expressing plant 
leaf. Arrows indicate presence of GFP in the intestinal epithelium as well as cells of the 
crypts.  
(d) Section of the ileum of a mouse fed with wild type (untransformed) plant leaf 
materials.  
(e) GFP- immunoreactivity in hepatocytes (arrows) in a mouse fed orally by CTB-GFP 
expressing plant. 
(f) Section of the liver from a mouse fed by wild type (untransformed) plant.  
(g) GFP- immunoreactivity in the spleen of mouse fed orally by CTB-GFP expressing 
plant. Arrows indicate various cells with a higher GFP content.  
(h) Section of the spleen from a mouse fed by wild type (untransformed) plant.  
Scale bar = 50 µm  
In order to see the fate of CTB in the body, we performed immunohistochemistry 
using anti-CTB antibodies. CTB was detected in the intestinal cells as well as inside the 
villi (fig. 10 A) in the lamina propia and the submucosa. It was however, not detected in 
the liver (Fig. 10 D) or the spleen, indicating that GFP is cleaved away from CTB in the 
intestinal cell and that while GFP leaves the cell, CTB probably is translocated to the 
basolateral membrane of the cell.  
To localize the GFP and/ or CTB in the gut associated lymphoid tissue (GALT) 
and other tissues double staining for antigen presenting cells such as macrophages or 
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dendritic cells was performed. A double staining with F4/80 antibody for macrophages 
showed CTB expression inside macrophages (Fig. 10 C). Fig. 10 G shows macrophages 
associated with GFP and fig. 10 I shows dendritic cells taking up the GFP. In either case, 
there are associations of GFP with these antigen presenting cells. Most of the 
macrophages were not associated with GFP, which is perhaps due to uptake by the blood 
and lymph circulation, while the CTB, is translocated to the basolateral membrane and is 











































Figure 10: Immunohistochemistry of ileum, liver, spleen tissues of mice fed with 
wildtype leaves or CTB-GFP or IFN-GFP expressing leaves. 
(a) Section of the intestine of a CTB-GFP treated mouse. The arrows indicate CTB in the 
submucosa of the intestinal villi.  
(b) Section of mouse ileum fed with wild type plant, immunostained for CTB.  
(c, d, e, f) Double staining for macrophage (red) and CTB (green) in mouse intestine and 
liver. (c) Arrows show macrophages in the submucosa of the intestine containing CTB, in 
a mouse fed with CTB-GFP expressing plant leaf material. The merged color is yellow. 
(d) Arrows indicate F4/80 positive cells (macrophages, in red) in a merged picture in the 
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intestine of a mouse fed with wild-type leaf material. (e) A merged picture showing 
double staining for macrophage (Kupffer cells) and CTB in mouse liver. Arrows show 
macrophages (red) in the liver. There is no sign of CTB (green) in the liver of CTB-GFP 
fed mouse. (f) Liver section of an IFN- GFP fed mouse used as a negative control for 
CTB. Macrophages are seen in red. 
(g) F4/80 antibody was used as a marker of macrophages in the intestine. Arrows indicate 
macrophages which have entrapped GFP (yellow after merging the red and the green). 
Many of the macrophages are not associated with GFP.  
(h) Many macrophages are seen in the intestine of mouse fed with IFN-GFP expressing 
plant leaf material, which do not show GFP immunoreactivity. 
(i and j) CD11c (red) and GFP (green) immunoreactivities. (i) Arrows indicate CD11c 
(red, presumably dendritic cells, due to having a star shape morphology) with internalized 
GFP (green) which can be seen in yellow color when the red and green channels were 
merged. (j) Arrows indicate CD11c positive cells in intestine of mice fed with IFN-GFP 
expressing plant leaf material.  
Scale bar for A and B = 25 µm 




In this study, detection of GFP and CTB in the intestinal mucosa (Fig. 8, 9) 
suggests that CTB–GFP has been taken up by the enterocytes and the gut-associated 
lymphoid tissue (GALT). The CTB domain of the CTB-GFP forms the pentameric 
structure within chloroplasts through disulfide bond formation; pentameric form binds to 
the GM1 receptors on enterocytes and is endocytosed into the intestinal cells as 
endosomes (Lencer 2001). GM1 functions to concentrate CTB in detergent-insoluble, 
glycolipid This study shows internalization of CTB-GFP by mouse intestinal mucosal 
cells as well as the antigen presenting cells in the intestinal mucosa and submucosa. We 
also showed the prescence of GFP but not CTB in the liver as well as the spleen of mice 
following oral delivery of CTB-GFP leaf material. Expression of both CTB and GFP in 
mouse intestinal cells following oral administration of transgenic chloroplast expressed 
CTB-GFP shows that the recombinant protein will be protected from peptidases and/or 
acids by bioencapsulation within the plant cells. In the intestine, certain enzymes break 
the linkages in the cellulose molecules causing pores to form in the wall through which 
proteins leave the plant cells into the intestinal lumen.  
In the current study, detection of GFP and CTB expressions in the intestinal 
mucosa (fig. 8, 9) suggests that CTB–GFP has been taken up by the enterocytes and the 
gut-associated lymphoid tissue (GALT). The CTB domain of the CTB-GFP forms the 
pentamer structure within chloroplasts through which it binds to the GM1receptors on 
enterocytes as well as the GALT cells and will be endocytosed into the intestinal cells as 
endosomes (Lencer, 2001). GM1functions to concentrate CTB in detergent-insoluble, 
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glycolipid rich apical membrane microdomains called lipid rafts (Orlandi and Fishman, 
1998; Brown and Lendon, 2000).  Binding to lipid rafts is required to couple the lipid-
anchored toxin with intracellular machinery for protein sorting and vesicular traffic 
(Lencer 1995; Wolf et al., 1998; Badizadegan et al., 2000). After endocytosis, the CTB-
GM1complex trafficking occurs retrogradely through Golgi cisternae and/ or trans-Golgi 
network (TGN, Lencer 1995 and 2001; Feng et al., 2004) into the lumen of the 
endoplasmic reticulum (ER, Fujinaga et al., 2003). The GM1-CTB-GFP complex in the 
lipid rafts, targeted to the TGN, loses it’s endosomal covering. Within the TGN, 
ubiquitously-expressed furin cleaves numerous polypeptide precursors as it gets 
activated. In eukaryotes, many essential secreted proteins and peptide hormones, 
enzymes and neuropeptides are initially synthesized as proproteins (inactive precursors) 
and are activated by proteolytic cleavage by member of a calcium-dependent 
endoproteases, the prohormone-proprotein convertases (PCs, Van den Ouweland et al., 
1990; Nakayama, 1997, Seidah and Chretien, 1998, Thomas, 2002).  Furin is the best-
characterized member of the PC family in the mammalian tissues and is located in trans-
Golgi network (TGN, Bosshart et al., 1994; Molloy et al., 1994) as well as in the 
endosomes and plasma membranes of polarized intestinal and renal epithelial cells and 
endothelial cells of the capillaries (Thomas 2002; Anderson et al., 2002; Mayer et al., 
2004). Crystal structure studies show that furin cleaves protein precursors with narrow 
specificity following basic Arg-Xaa-Lys/ Arg-Arg-like motifs (Henrich et al., 2003). 
There is abundant experimental evidence that the CTB-GFP protein with furin cleavage 
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site in between the fusion protein gets cleaved during retrograde trafficking in the TGN 
and as a result the CTB and GFP get separated.  
The CTB is taken into the ER and from there to the baso-lateral surface of the cell 
(transcytosis), where it remains membrane bound to GM1receptor (Lencer, 2001). The 
GFP molecule getting out of the TGN (presumably membrane bound) is exocytosed 
through the basolateral membrane and finds its way into extracellular fluid and into the 
submucosal vessels including the lymphatic system.  
Due to the large size fenestrations of the lymphatic vessels, lymphatics return 
over 3L of fluid and approximately 120g of protein to the blood stream every 24 hours in 
an adult human (Granger D.N., in Essential medical physiology).  Beside, the entry of 
CTB-GFP through the GM1 ganglioside receptor, the M cells in intestinal epithelium 
covering the mucosa associated lymphoid tissue in the digestive tract also serve as the 
port of entry by pinocytosis (Sansonetti, 1999). M cells internalize macromolecules and 
microorganisms efficiently and deliver them to the underlying antigen presenting cells. 
Small amount of GFP associated with macrophages in the intestine of the INF-GFP fed 
mice is likely to be taken up by the M-cells non-specifically. The IFN- GFP fusion 
protein also contains a furin cleavage site, but due to limited uptake by the intestinal 
epithelial cells, there is not a significant GFP transport to the tissues of the IFN-GFP fed 
mice. The amount of CTB-GFP reaching the enterocytes via GM1 receptor is very high 
compared to the entry of IFN-GFP through M-cells. This is quite evident due to the GFP 
detected in various organs of the CTB-GFP fed mice (fig: 8, 9). Presence of GFP and not 
CTB in the liver and/or spleen of CTB-GFP treated mice in our current study (fig: 8, 9) 
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indicates that the cleavage of the CTB-GFP fusion protein in enterocytes and uptake of 
GFP into the vasculature of the lamina propia and the submucosa. CTB however, might 
be translocated to the basolateral cell membrane and remain bound to GM1 (Lencer 
2001).  
The main focus of our current study using GFP as a model protein (of therapeutic 
value) conjugated to CTB with a furin cleavage site expressed in plants is to show an 
efficient oral delivery of protein through GM1 receptor mediated endocytosis. Moreover, 
furin cleavage site facilitates the cleavage of the candidate protein in the cell, so that it 
could be passed into the extracellular space and into the circulation. Internalization of 
GFP using receptor mediated endocytosis suggests a possible way of protein delivery 
across the impermeable intestinal mucous membrane. Since there is a rapid turnover of 
the intestinal epithelial cells (Heath JP, 1996) in human (renewal of the intestinal 
epithelium occurs in every 3-6 days), repeated feeding of the CTB fused to a therapeutic 
protein is possible due to the continuous availability of GM1 receptors in the new 
epithelium. Moreover Peterson and colleagues suggested a recycling mechanism for 
GM1receptor as well (Boonyarattanakalin S, 2004 et al.,)  
In addition, it is known that the M cells transport the macromolecules and 
antigens to the underlying lymphoid tissue (GALT) (Jepson 1998).  Therefore, a small 
amount of CTB-GFP could be untaken by the GALT.  This is shown in our current study 
by CTB and GFP expression in the antigen presenting cells including the macrophages as 
well as the dendritic cells in the intestinal lamina propia and submucosa. 
 52
Ability of cholera-like enterotoxins to act as adjuvants to unrelated antigens to 
increase the systemic antibody titer was first reported by Northrup and Fauci (1972). 
Many investigators have used CT as an adjuvant to boost immune responses to unrelated 
antigens, hence, increasing the mucosal and systemic antibodies through oral vaccines 
(Elson and Ealding, 1984; Clements et al, 1988; Millar et al, 2001). On the other hand, 
recent evidences suggest that oral administration of CTB conjugated to insulin (Arakawa 
et al., 1998) or CTB conjugated to myelin basic protein (Sun et al., 2000) induces 
tolerance and decreases the autoimmunity in animal model of type1 diabetes (Arakawa et 
al., 1998) or experimental autoimmune encephalomyelitis (Sun et al., 2000), perhaps 
through Th2 and Th3 immunomodulation and induction of immunosuppressive cytokines 
such as IL4 and IL10 and TGF-β.   
In either way, involvement of the intestinal antigen presenting cells as it is shown 
in our current study is the first step towards immunity and/or immunosuppression. 
Association of macrophages and dendritic cells with CTB and/or GFP in our study shows 
the efficacy of our plant expressing fusion proteins in involving the intestinal lymphoid 
tissue as well.  
The high cost of therapeutic proteins can be attributed to their production in 
fermentation based system, purification using expensive methods including 
chromatography, low temperature storage, transportation and sterile delivery through 
health professionals. Most of the expenses could be avoided by expressing therapeutic 
proteins in plant cells and their oral delivery. The ability to express high levels of foreign 
proteins in edible plant parts (Kumar et. al, 2004a) makes this approach a reality. 
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CONCLUSIONS 
This study demonstrates the use of CTB as an efficient transmucosal carrier 
system to carry biopharmaceuticals across the intestinal membrane. GFP is used as a 
visible marker in this proof of concept project. It shows internalization of CTB-GFP by 
the mouse intestinal mucosal cells as well as the antigen presenting cells in the intestinal 
mucosa and submucosa. We also showed the presence of GFP but not CTB in the liver of 
mice following oral delivery of CTB-GFP leaf material. Detection of both CTB and GFP 
in mouse intestinal cells following oral administration of CTB-GFP expressing leaf 
material shows that the recombinant protein has been protected from peptidases and/or 
acids by bioencapsulation within the plant cells. The high cost of therapeutic proteins can 
be attributed to their production in fermentation based system, purification using 
expensive methods including chromatography, low temperature storage, transportation 
and sterile delivery using syringes through health professionals. Most of these expenses 
could be avoided by expressing therapeutic proteins in plant cells and through their oral 
delivery. The ability to express high levels of foreign proteins in edible plant parts makes 
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